Progestins and bone
Abstract
Since the introduction of hormone replacement therapy which combines administration of oestrogens with cyclic or continuous administration of progestins, attention has been paid to the possible modulating effect of the progestin on the beneficial effects of the oestrogens. In this review data regarding the effects of progestins and of oestrogen/progestin combinations on bone in women have been summarized. The conclusion is that there is no evidence for a negative influence of progestins on the beneficial effects of oestrogens on the bone. To the contrary, progestins seem to have additional bone sparing properties because they are capable of stimulating the formation of bone, but the exact mechanism is still under discussion.
Read the paper
Related studies
- Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2)
- In silico and in vitro studies: investigating the chemical composition, DFT, molecular docking, and dynamic simulation of Satureja candidissima (Munby) Briq essential oil as a potential antibacterial agent
- Quercetin combined with ciprofloxacin and gentamicin inhibits biofilm formation and virulence in Staphylococcus aureus
- In silico study of the mechanism of action, pharmacokinetic and toxicological properties of some N-methylanthranilates and their analogs
- Anticonvulsant Effects of Citronellal, Daidzin, and Phytol, Possibly Through GABAA Receptor and Voltage-Gated Sodium Channel Interaction Pathways: In Vivo and In Silico Studies
- 2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as D3R-Selective Ligands for 3D-QSAR, Docking and Molecular Dynamics Simulation Studies
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.